Presbyond Lbv For The Correction Of Presbyopia In Myopic Patients – Assessment Of Effectiveness, Safety And Patient Satisfaction.

To evaluate the safety, efficacy, stability and patient satisfaction of Presbyond Laser Blended Vision (LBV) for the correction of presbyopia in myopic patients. 

Private clinical ophthalmology practice.

This retrospective analysis included 100 eyes of 50 myopic patients with presbyopia treated by Presbyond LBV using the non-linear aspheric ablation profile with the MEL 90 (Carl Zeiss Meditec, Jena, Germany) and femtosecond laser VisuMax to create the flap. The target refraction was plano for distance eyes (dominant eye) and between -1,12 and -2.0 diopters (D) for near eyes. Mean corrected myopia was -4,41±1,47D (range: -1,25D to -8,75D) Mean age was 45 years (range: 40 to 55 years). Patients were followed for one year after surgery. 30 patients participated in the satisfaction survey.

Postoperative spherical equivalent in dominant eye was ±0,50D in 94% of eyes. Of the distance eyes, 92% of eyes achieved uncorrected visual acuity of 20/20 and 100% of eyes achieved 20/25. Binocularly, 98% of patients achieved 20/20 and 100% achieved 20/25. Binocularly, 98% patients could read 0,5 on Snellen charts. No eyes lost two or more lines in best spectacle-corrected visual acuity.The results of the satisfaction survey clearly revel that none of the patients surveyed consider reducing micromonvision (100% satisfied patients).Each of the subjects experienced full neuroadaptation, and each of them would repeat the procedure knowing the final effect. 100% of patients undergoing the procedure does not use glasses for far and near vision.

Presbyond LBV is safe, effective and stable for treating presbyopia in myopic patients.